Assignee
SCHEPENS EYE RES INST
US·73 granted patents·64 pending applications·1,534 citations·filing 1992–2025
Top patents by PatentIndex Score
137 records- 0194US11241497B2Therapeutic compositions for treatment of ocular inflammatory disordersSCHEPENS EYE RES INST·Filed 2017·Granted Feb 8, 2022·7 cites·10 claims
- 0293US6107289AOcular therapy in keratoconjunctivitis sicca using topically applied androgens or TGF-βSCHEPENS EYE RES INST·Filed 1999·Granted Aug 22, 2000·124 cites·37 claims
- 0391US5958912AOcular therapy in keratoconjunctivitis sicca using topically applied androgens of TGF-βSCHEPENS EYE RES INST·Filed 1997·Granted Sep 28, 1999·116 cites·4 claims
- 0490US10179160B2Therapeutic compositions for the treatment of dry eye diseaseSCHEPENS EYE RES INST·Filed 2016·Granted Jan 15, 2019·3 cites·16 claims
- 0590US5620921AOcular androgen therapy in sjogren's syndromeSCHEPENS EYE RES INST·Filed 1993·Granted Apr 15, 1997·79 cites·12 claims
- 0690US2025195608A1Therapeutic Compositions for the Treatment of Dry Eye DiseaseSCHEPENS EYE RES INST·Filed 2024·Application pending·0 cites
- 0789US11692029B2Therapy for glaucoma and optic neuropathy by targeting colony stimulating factorsSCHEPENS EYE RES INST·Filed 2019·Granted Jul 4, 2023·7 cites·20 claims
- 0888US10449234B2Compositions and methods for prevention and treatment of corneal haze and scarringSCHEPENS EYE RES INST·Filed 2016·Granted Oct 22, 2019·3 cites·8 claims
- 0988US5718922AIntravitreal microsphere drug delivery and method of preparationSCHEPENS EYE RES INST·Filed 1995·Granted Feb 17, 1998·189 cites·18 claims
- 1087US5309339AConcentrator for laser lightSCHEPENS EYE RES INST·Filed 1992·Granted May 3, 1994·55 cites·22 claims
- 1186US7514259B2Isolation and transplantation of retinal stem cellsSCHEPENS EYE RES INST·Filed 2001·Granted Apr 7, 2009·30 cites·7 claims
- 1285US11680266B2Endomucin inhibitor as an anti-angiogenic agentSCHEPENS EYE RES INST·Filed 2020·Granted Jun 20, 2023·2 cites·18 claims
- 1385US5545617ATherapeutic regulation of abnormal conjunctival goblet cell mucous secretionSCHEPENS EYE RES INST·Filed 1993·Granted Aug 13, 1996·101 cites·7 claims
- 1485US2025145949A1Low Oxygen Culture Conditions for Maintaining Retinal Progenitor Cell MultipotencySCHEPENS EYE RES INST·Filed 2024·Application pending·0 cites
- 1584US10940179B2Therapeutic compositions for the treatment of dry eye diseaseSCHEPENS EYE RES INST·Filed 2018·Granted Mar 9, 2021·2 cites·10 claims
- 1683US11229662B2Compositions and methods for the treatment of aberrant angiogenesisSCHEPENS EYE RES INST·Filed 2017·Granted Jan 25, 2022·2 cites·15 claims
- 1783US6548059B1Promotion of proliferation of adult corneal endothelial cellsSCHEPENS EYE RES INST·Filed 2000·Granted Apr 15, 2003·17 cites·12 claims
- 1881US2025231200A1Blood Biomarkers and Diagnostic Methods for Small Vessel DiseasesSCHEPENS EYE RES INST·Filed 2024·Application pending·0 cites
- 1981US2023285500A1Compositions and Methods for Gene Therapy for Corneal Endothelium DisordersSCHEPENS EYE RES INST·Filed 2023·Application pending·0 cites
- 2081US2024123032A1Compositions and methods for prevention and treatment of corneal haze and scarringSCHEPENS EYE RES INST·Filed 2023·Application pending·0 cites
- 2180US12226156B2Measuring eye refractionSCHEPENS EYE RES INST·Filed 2024·Granted Feb 18, 2025·0 cites·7 claims
- 2280US6541256B1Growth medium for human corneal endothelial cellsSCHEPENS EYE RES INST·Filed 2000·Granted Apr 1, 2003·15 cites·2 claims
- 2379US9872901B2Therapeutic compositions for treatment of ocular inflammatory disordersSCHEPENS EYE RES INST·Filed 2016·Granted Jan 23, 2018·2 cites·20 claims
- 2479US7316927B2Culture of goblet cellsSCHEPENS EYE RES INST·Filed 2006·Granted Jan 8, 2008·2 cites·6 claims
- 2579US6611618B1Wide-band image enhancementSCHEPENS EYE RES INST·Filed 1999·Granted Aug 26, 2003·70 cites·28 claims
- 2678US12188950B2Blood biomarkers and diagnostic methods for small vessel diseasesSCHEPENS EYE RES INST·Filed 2022·Granted Jan 7, 2025·0 cites·20 claims
- 2778US6218360B1Collagen based biomaterials and methods of preparation and useSCHEPENS EYE RES INST·Filed 1999·Granted Apr 17, 2001·59 cites·16 claims
- 2877US2022088119A1Therapeutic compositions for the treatment of dry eye diseaseSCHEPENS EYE RES INST·Filed 2021·Application pending·0 cites
- 2977US2025161402A1Therapeutic compositions for the treatment of dry eye diseaseSCHEPENS EYE RES INST·Filed 2025·Application pending·0 cites
- 3076US6667173B2Nucleic acids encoding platelet derived growth factor-alpha receptorsSCHEPENS EYE RES INST·Filed 2001·Granted Dec 23, 2003·13 cites·40 claims
- 3176US2021154263A1Therapeutic compositions for the treatment of dry eye diseaseSCHEPENS EYE RES INST·Filed 2021·Application pending·0 cites
- 3275US12295985B2Methods of reducing severity of glaucoma by intravitreal administration of insulin-like growth factor binding protein-like 1 (IGFBPL1)SCHEPENS EYE RES INST·Filed 2022·Granted May 13, 2025·0 cites·12 claims
- 3375US11937877B2Measuring dark adaptationSCHEPENS EYE RES INST·Filed 2019·Granted Mar 26, 2024·2 cites·18 claims
- 3475US11759499B2Compositions and methods for prevention and treatment of corneal haze and scarringSCHEPENS EYE RES INST·Filed 2021·Granted Sep 19, 2023·0 cites·10 claims
- 3575US7374284B2Peripheral field expansion deviceSCHEPENS EYE RES INST·Filed 2004·Granted May 20, 2008·22 cites·16 claims
- 3675US5563710AImaging system with confocally self-detecting laserSCHEPENS EYE RES INST·Filed 1994·Granted Oct 8, 1996·67 cites·21 claims
- 3775US2019151404A1Therapeutic compositions for the treatment of dry eye diseeaseSCHEPENS EYE RES INST·Filed 2018·Application pending·0 cites
- 3874US12234282B2Therapy for glaucoma and optic neuropathy by targeting colony stimulating factorsSCHEPENS EYE RES INST·Filed 2023·Granted Feb 25, 2025·0 cites·18 claims
- 3974US11739326B2RUNX1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transitionSCHEPENS EYE RES INST·Filed 2018·Granted Aug 29, 2023·1 cites·33 claims
- 4074US10780070B2Alpha-aminoadipate for treatment of vision loss and restoring sightSCHEPENS EYE RES INST·Filed 2014·Granted Sep 22, 2020·1 cites·14 claims
- 4174US5688765AOcular therapy in Sjogren's syndrome using topically applied androgensor TGF-βSCHEPENS EYE RES INST·Filed 1995·Granted Nov 18, 1997·33 cites·4 claims
- 4274US2025064977A1Nucleic Acid-Based Compositions and Methods for Treating Small Vessel DiseasesSCHEPENS EYE RES INST·Filed 2024·Application pending·0 cites
- 4374US2025151999A1Measuring eye refractionSCHEPENS EYE RES INST·Filed 2025·Application pending·0 cites
- 4472US2025000897A1Oxygenated emulsion for treatment of ocular injurySCHEPENS EYE RES INST·Filed 2024·Application pending·0 cites
- 4571US12551100B2Measuring dark adaptationSCHEPENS EYE RES INST·Filed 2024·Granted Feb 17, 2026·0 cites·9 claims
- 4671US11583497B2Nano-emulsion of CBFß-RUNX1 inhibitor for ocular drug deliverySCHEPENS EYE RES INST·Filed 2018·Granted Feb 21, 2023·1 cites·6 claims
- 4771US5368582AMethod and apparatus for introducing fluid material into an eyeSCHEPENS EYE RES INST·Filed 1992·Granted Nov 29, 1994·176 cites·18 claims
- 4869US11260048B2Compounds and compositions for inhibiting retinal pigment epithelium degeneration and methods using the sameSCHEPENS EYE RES INST·Filed 2018·Granted Mar 1, 2022·1 cites·13 claims
- 4969US6775060B2Bioptic telescope system embedded into a spectacle lensSCHEPENS EYE RES INST·Filed 2001·Granted Aug 10, 2004·20 cites·13 claims
- 5069US2020121758A1Compositions and methods for prevention and treatment of corneal haze and scarringSCHEPENS EYE RES INST·Filed 2019·Application pending·0 cites
Showing the top 50 of 137 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when SCHEPENS EYE RES INST files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →